Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers

NCT04267640 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease
Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease
Chronic Limb Threatening Ischemia
Ischemic Ulcer of Foot

Interventions

BIOLOGICAL: AMG0001
BIOLOGICAL: Placebo

Sponsor

AnGes USA, Inc.